Psychotherapeutic Benefits of Opioid Agonist Therapy

REFERENCES

• Hodgson , B . 1999 . Opium: A Portrait of a Heavenly Demon , San Francisco : Chronicle Books .
   Google Scholar
• Bendick , J . 2002 . Galen and the Gateway to Medicine , Bathgate, ND : Bethlehem Books .
   Google Scholar
• De Quincey , T . 2003 . Confessions of an English Opium Eater (1822) , London : Penguin Classics .
   Google Scholar
• White , W L . 1998 . Slaying the Dragon: The History of Addiction in America , Bloomington, IL : Chesnut Health Systems Publications .
   Google Scholar
• December 17 1914 . December 17 , Harrison Narcotic Tax Act. Public Law No. 223, 63rd Cong., approved
   Google Scholar
• Varga , E . 1982 . The effect of codeine on involutional and senile depression . Ann N Y Acad Sci , 398 : 103 – 5 .
   PubMed Web of Science ®Google Scholar
• Kraepelin , E . 1905 . Einführung in die psychiatrische Klinik: zweiunddreissig Vorlesungen , Leipzig : J.A. Barth .
   Google Scholar
• Belluzzi , J and Stein , L . 1977 . Enkephaline may mediate euphoria and drive-reduction reward . Nature , 266 ( 5602 ) : 556 – 8 .
   PubMed Web of Science ®Google Scholar
• Ikemoto , S and Panksepp , J . 1999 . The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking . Brain Res Rev , 31 ( 1 ) : 6 – 41 .
   PubMed Web of Science ®Google Scholar
• Gross-Isseroff , R , Dillon , K , Israeli , M and Biegon , A . 1990 . Regionally selective increases in mu opioid receptor density in the brains of suicide victims . Brain Res , 530 ( 2 ) : 312 – 6 .
   PubMed Web of Science ®Google Scholar
• Naber , D , Pickar , D , Post , R , Van Kammen , D , Waters , R , Ballenger , J , Goodwin , F and Bunney , W . 1981 . Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers . Am J Psychiatry , 138 ( 11 ) : 1457 – 62 .
   PubMed Web of Science ®Google Scholar
• Sweetmen , S C , Blake , P S , McGlashan , J M , Neathercoat , G C and Parsons , A V , eds. 2006 . Martindale: The Complete Drug Reference. , 35th Edition , London : Pharmaceutical Press .
   Google Scholar
• Halbreich , M and Endicott , J . 1981 . Possible involvement of endorphin withdraw in postpartum depression . Medical Hypotheses , 7 : 1054 – 8 .
   Web of Science ®Google Scholar
• Emrich , H , Vogt , P and Herz , A . 1982 . Possible antidepressive effects of opioids: Action of buprenorphine . Ann N Y Acad Sci , 398 : 108 – 12 .
   PubMed Web of Science ®Google Scholar
• Bodkin , J , Alexander , M , Zornberg , G , Lukas , S and Cole , J . 1995 . Buprenorphine treatment of refractory depression . Jour of Clin Psychopharm , 15 ( 1 ) : 49 – 57 .
   PubMed Web of Science ®Google Scholar
• Resnick , R and Falk , F . 1987 . “ Buprenorphine: Pilot trials in borderline patients and opiate dependence ” . In NIDA Research Monograph: Problems of Drug Dependence , Edited by: Harris , L B . Washington, D.C. : U.S. Government Printing Office .
   Google Scholar
• Callawaye , E . 1996 . Buprenorphine for depression . Biological Psychiatry , 39 ( 12 ) : 989 – 90 .
   PubMed Web of Science ®Google Scholar
• Morgan , L and Callowaye , E . 1990 . Buprenorphine responders . Biological Psychiatry , 28 : 1078 – 80 .
   PubMed Web of Science ®Google Scholar
• Kosten , T , Morgan , C and Kosten , T . 1990 . Depressive symptoms during buprenorphine treatment of opioid abusers . J Subst Abuse Treat , 7 ( 1 ) : 51 – 4 .
   PubMed Web of Science ®Google Scholar
• Maremmani , I , Pacini , M and Pani , P . 2006 . Effectiveness of buprenorphine in double diagnosed patients. Buprenorphine as a psychotropic drug . Heroin Add Rel Clin Probl , 8 ( 1 ) : 31 – 48 .
   Google Scholar
• Dean , A , Bell , J , Christie , M and Mattick , R . 2004 . Depressive symptoms during buprenorphine vs. methadone maintenance: findings from a randomised, controlled trial in opioid dependence . Eur Psychiatry , 19 ( 8 ) : 510 – 3 .
   PubMed Web of Science ®Google Scholar
• Dean , A , Bell , J , Mascord , D , Parker , G and Macdonald , C . A trial of fluoxetine in methadone maintenance patients with depression . J Aff Disord , 72 ( 1 ) 85 – 90 .
   PubMed Web of Science ®Google Scholar
• Dyer , K , White , J , Foster , D , Bochner , F , Memelaou , A and Somogyi , A . 2001 . Mood state and methadone plasma concentrations . J Clin Psychopharm , 21 ( 1 ) : 78 – 84 .
   PubMed Web of Science ®Google Scholar
• McNair , D M , Lorr , M and Droppelman , L F . 1992 . Profile of Mood States Manual , San Diego, CA : Educational and Industrial Testing Service .
   Google Scholar
• De Montis , G , Devoto , P and Tagliamonte , A . 1892 . Possible antidepressant activity of methadone . Euro J Pharm , 79 ( 1–2 ) : 145 – 6 .
   Web of Science ®Google Scholar
• Drevets , W , Frank , E , Price , J , Kupfer , D , Holt , D , Greer , P , Huang , Y , Gautier , C and Mathis , C . 1999 . PET imaging of serotonin 1A receptor binding in depression . Biol Psychiatry , 46 ( 10 ) : 1375 – 87 .
   PubMed Web of Science ®Google Scholar
• Rosa-Neto , P , Diksic , M , Okazawa , H , Leyton , M , Ghadirian , N , Mzengeza , S , Nakai , A , Debonnel , G , Blier , P and Benkelfat , C . 2004 . Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression . Arch Gen Psychiatry , 61 ( 6 ) : 556 – 63 .
   PubMed Web of Science ®Google Scholar
• Neumeister , A , Bain , E , Nugent , A , Carson , R , Bonne , O , Luckenbaugh , D , Eckelman , W , Herscovitch , P , Charney , D and Drevets , W . 2004 . Reduced serotonin type 1A receptor binding in panic disorder . J Neurosci , 24 ( 3 ) : 589 – 91 .
   PubMed Web of Science ®Google Scholar
• Williams , J , Mulrow , C , Chiquette , E , Noel , P , Aguilar , C and Cornell , J . 2000 . A systematic review of newer pharmacotherapies for depression in adults: evidence report summary . Ann Intern Med , 132 ( 9 ) : 743 – 56 .
   PubMed Web of Science ®Google Scholar
• Ciofalo , F . 1974 . Methadone inhibition of 5-hydroxytryptamine uptake . J Pharmacol Exp Ther , 189 ( 1 ) : 83 – 9 .
   PubMed Web of Science ®Google Scholar
• Gillman , P . 2005 . Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity . Br J Anaesth , 95 ( 4 ) : 434 – 41 .
   PubMed Web of Science ®Google Scholar
• Maremmani , I , Matteo , P , Lubrano , S , Lovreded , M and Perugi , G . 2003 . Dual diagnosis heroin addicts: the clinical and therapeutic aspects . Heroin Add Rel Clin Probl , 5 ( 2 ) : 7 – 98 .
   Google Scholar
• Hamilton , S , Nunes , E , Janal , M and Weber , L . 2000 . The Effect of sertraline on methadone plasma levels in methadone maintenance patients . Am J Addict , 9 : 63 – 9 .
   PubMed Web of Science ®Google Scholar
• Eap , C , Gilles , M , Powell , K and Baumann , P . 1997 . Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of enantiomers of methadone . J Clin Psychopath , 17 ( 2 ) : 113 – 7 .
   Web of Science ®Google Scholar
• Berge , S , von Bardeleben , U , Ladewig , D , Jaquet , S , Cosendai , L , Golay , K , Kosel , M , Baumann , P and Eap , C . 2002 . Paroxetine increases steady state concentrations of methadone . J Clin Psychopharmacol , 22 ( 2 ) : 211 – 5 .
   PubMed Web of Science ®Google Scholar
• Waugh , J and Goa , K . 2003 . Escitalopram: a review of its use in the management of major depressive and anxiety disorders . CNS Drugs , 17 : 343 – 62 .
   PubMed Web of Science ®Google Scholar
• Meyer , J H , Ginovart , N , Boovariwala , A , Boovariwala , A , Sagrati , S , Hussey , D , Garcia , A and Young , T . 2006 . Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression . Arch Gen Psychiatry , 63 ( 11 ) : 1209 – 16 .
   PubMed Web of Science ®Google Scholar
• VanderWende , C and Spoerlein , M . 1979 . Effect of narcotics on monoamine oxidase activity of mouse brain . Res Chem Pathol Pharmacol , 24 ( 1 ) : 103 – 13 .
   PubMedGoogle Scholar
• Lee , S , Lee , J , Cheong , M , Kim , H , Kim , Y , Yun , Y , Lee , C and Lee , M . 2001 . Inhibitory effects of ethaverine on monoamine oxidase activity in mouse brain . Biol Pharm Bull , 24 ( 7 ) : 838 – 40 .
   PubMed Web of Science ®Google Scholar
• Sachar , E , Hellman , L , Roffwarg , H , Halpern , F , Fukushima , D and Gallagher , T . 1973 . Disrupted 24-hour patterns of cortisol secretion in psychotic depression . Arch Gen Psychiatry , 28 ( 1 ) : 19 – 24 .
   PubMed Web of Science ®Google Scholar
• Gold , P , Extein , I , Pickar , D , Rebar , R , Ross , R and Goodwin , F . 1980 . Supression of plasma cortisol in depressed patients by acute intravenous methadone infusion . Am J Psychiatry , 137 ( 7 ) : 862 – 3 .
   PubMed Web of Science ®Google Scholar
• Judd , L , Parker , D , Janowsky , D , Segal , D , Risch , S and Huey , L . 1982 . The effect of methadone on the behavioral and neuroendocrine responses of manic patients . Psychiatry Res , 7 ( 2 ) : 163 – 70 .
   PubMed Web of Science ®Google Scholar
• Paul , I and Skolnick , P . 2003 . Glutamate and depression . Ann N Y Acad Sci , 1003 : 250 – 7 .
   PubMed Web of Science ®Google Scholar
• Bergink , V , van Megen , H and Westenberg , H . 2004 . Glutamate and anxiety . Eur Neuropsychopharmacol , 14 ( 3 ) : 175 – 83 .
   PubMed Web of Science ®Google Scholar
• Callahan , R , Au , J , Liu , C and Yost , C . 2004 . Functional inhibition by methadone of NMDA receptors . Anesth Analg , 98 ( 3 ) : 653 – 9 .
   PubMed Web of Science ®Google Scholar
• Zarate , C , Singh , J , Carlson , P , Brutsche , N , Ameli , R and Luckenbaugh , D . 2006 . A randomized trial of NMDA antagonist in major depression . Arch Gen Psychiatry , 63 ( 8 ) : 856 – 64 .
   PubMed Web of Science ®Google Scholar
• Gorman , A , Elliott , K and Inturrisi , C . 1997 . The d-and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord . Neurosci Lett , 223 ( 1 ) : 5 – 8 .
   PubMed Web of Science ®Google Scholar
• Berman , R , Cappiello , A , Anand , A and Oren , D . 2000 . Antidepressant effects of ketamine in depressed patients . Biol Psych , 47 ( 4 ) : 351 – 4 .
   PubMed Web of Science ®Google Scholar
• Ebert , B , Andersen , S and Krogsgaard , P . 1995 . Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord . Neurosci Lett , 187 ( 3 ) : 165 – 8 .
   PubMed Web of Science ®Google Scholar
• Davis , A and Inturrisi , C . 1999 . Methadone blocks morphine tolerance and NMDA induced hyperalgesia . Pharmacol and Exper Therap , 289 ( 2 ) : 1048 – 53 .
   PubMed Web of Science ®Google Scholar
• Pani , P , Trogu , E , Carboni , G , Palla , P and Loi , A . 2003 . Psychiatric severity and treatment response in methadone programs . Heroin Add Rel Clin Probl , 5 ( 3 ) : 23 – 36 .
   Google Scholar
• Maremmani , I , Zolesi , O , Agueci , T and Castrogiovanni , P . 1993 . Methadone doses and psychopathological symptons during methadone maintenance . J Psychoact Drug , 25 ( 3 ) : 253 – 6 .
   PubMed Web of Science ®Google Scholar
• Pani , P , Trogu , E , Contu , P , Agus , A and Gessa , G . 1997 . Psychiatric severity and treatment response in a comprehensive methadone maintenance treatment program . Drug Alcohol Depend , 48 ( 2 ) : 119 – 26 .
   PubMed Web of Science ®Google Scholar
• Lomas , L and Picker , M . 2005 . Behavioral assessment of temporal summation in the rat: sensitivity to sex, opioids and modulation by NMDA receptor antagonists . Psychopharmacology (Berl) , 180 ( 1 ) : 84 – 94 .
   PubMed Web of Science ®Google Scholar
• Tatarczynska , E . 2001 . Potential anxiolytic effects of MPEP . Br J Pharmacol , 132 ( 7 ) : 1423 – 30 .
   PubMed Web of Science ®Google Scholar
• Mirza , N , Bright , J , Stanhope , K , Wyatt , A and Harrington , N . 2005 . Lamotrignine has an anxiolytic-like profile in rats . Psychopharmacology , 180 ( 1 ) : 159 – 68 .
   PubMed Web of Science ®Google Scholar
• Klodzinska , A and Tatarczynska , E . 2004 . Anxiolytic effects of MTEP . Neuropharmacology , 47 ( 3 ) : 342 – 50 . Sep
   PubMed Web of Science ®Google Scholar
• Becqet , D , Hery , M , Francois , A , Giraud , P , Deprez , P , Faudon , M , Fache , M and Hery , F . 1993 . Glutamate, GABA, glycine and taurine modulate serotonin synthesis and release in rostral and caudal rhombencephalic raphe cells in primary cultures . Neurochem Int , 23 ( 3 ) : 269 – 83 .
   PubMed Web of Science ®Google Scholar
• Rybakowski , J . 2007 . Long-term pharmacological treatment of bipolar disorders . Neuro Endocrinol Lett , 28 ( Suppl1 ) : 71 – 93 .
   PubMed Web of Science ®Google Scholar
• Rosenberg , D , MacMaster , F , Keshavan , M , Fitzgerald , K , Stewart , C and Moore , G . 2000 . Decrease in Caudate Glutamate in OCD . J Am Acad Child Adol Psych , 39 ( 9 ) : 1096 – 103 .
   PubMed Web of Science ®Google Scholar
• Owen , J and Whitton , P . 2006 . Chronic treatment with antidepressants reverses NMDA mediated regulation of 5-HT in rat brain . Brain Res Bull , 70 ( 1 ) : 62 – 7 .
   PubMed Web of Science ®Google Scholar
• Stachowicz , K , Chojnacka , E , Klak , K and Pilc , A . Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent . Neuropharmacology , 52 ( 2 ) Feb : 306 – 12 .
   PubMed Web of Science ®Google Scholar
• Goldsmith , M , Shapira , N and Keck , P . 1999 . Rapid remission of OCD with tramadol hydrochloride . Am J Psychiatry , 156 : 660 – 1 .
   PubMed Web of Science ®Google Scholar
• Shapira , N , Keck , P , Golsdmith , T , McConville , B , Eis , M and McElroy , S . 1997 . Open-label pilot study of tramadol hydrochloride in treatment-refractory obsessive-compulsive disorder . Depress Anxiety , 6 ( 4 ) : 170 – 3 .
   PubMedGoogle Scholar
• Khazaal , Y , Krenz , M and Zullino , D . 2006 . Worsening of OCD symptome under methadone tapering . Prog Neuropsychopharmacol Biol Psychiatry , 30 ( 7 ) : 350 – 2 .
   Web of Science ®Google Scholar
• Zhu , W and Pan , Z . 2005 . Mu-opioid-mediated inhibition of glutamate synaptic transmission in rat central amygdala neurons . Neuroscience , 133 ( 1 ) : 97 – 103 .
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association . 2000 . Diagnostic and Statistical Manual of Mental Disorders., , 4th Edition , Washington, D.C. : Author . Text Revision
   Google Scholar
• Peles , E , Schreiber , S and Adelson , M . 2006 . Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel . Drug Alcohol Depend , 82 ( 3 ) : 211 – 7 .
   PubMed Web of Science ®Google Scholar
• Mason , B , Kocsis , J , Melia , D , Khuri , E , Sweeney , J , Wells , A , Borg , L , Millman , R and Kreek , M . 1998 . Psychiatric comorbidity in methadone maintained patients . J Addic Diseas , 17 ( 3 ) : 75 – 89 .
   PubMed Web of Science ®Google Scholar
• Peles , E , Schreiber , S , Naumovsky , Y and Adelson , M . 2006 . Depression in methadone maintenance treatment patients . J Affect Disord , [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Ross , J , Teesson , M , Darke , S , Lynskey , M , Ali , R , Ritter , A and Cooke , R . 2005 . The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS) . Drug Alcohol Rev , 24 ( 5 ) : 411 – 8 .
   PubMed Web of Science ®Google Scholar
• Maremmani , I , Zolesi , O , Agletti , M , Tagliamonte , A , Shinderman , M and Maxwell , S . 2000 . Methadone dose and retention during treatment of heroin addicts with axis 1 psychiatric comorbidity . J Addic Dis , 19 ( 2 ) : 29 – 41 .
   PubMed Web of Science ®Google Scholar
• Villafranca , S , Mckellar , J , Trafton , J and Humphreys , K . 2006 . Predictors of retention in methadone programs: a signal detection analysis . Drug Alcohol Depend , 83 ( 3 ) : 218 – 24 .
   PubMed Web of Science ®Google Scholar
• Farre , M , Mas , A , Torrens , M , Moreno , V and Cami , J . 2002 . Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis . Drug Alcohol Depend , 65 ( 3 ) : 283 – 90 .
   PubMed Web of Science ®Google Scholar
• Brady , T , Salvucci , S , Sverdlov , L , Male , A , Kyeyune , H , Sikali , E , DeSale , S and Yu , P . 2005 . Methadone dosage and retention: an examination of the 60 mg/day threshold . J Addict Dis , 24 ( 3 ) : 23 – 47 .
   PubMed Web of Science ®Google Scholar
• Maxwell , S and Schinderman , M . 2002 . Optimizing long-term response to methadone maintenance treatment: a 152-week follow-up using higher-dose methadone . J Addict Dis , 21 ( 3 ) : 1 – 12 .
   PubMed Web of Science ®Google Scholar
• Torres , M , Castillo , C and Perez , V . 1996 . Retention in a low-threshold methadone maintenance program . Drug Alcohol Depend , 41 ( 1 ) : 55 – 9 .
   PubMed Web of Science ®Google Scholar
• Trafton , J , Minkel , J and Humphreys , K . 2006 . Determining effective methadone doses for individual dependent patients . PLoS Med , 3 ( 3 ) : 80 – 94 .
   PubMed Web of Science ®Google Scholar
• Tenore , P . CARF Review Data File, Oct 2000, Albert Einstein College of Medicine, Division of Substance Abuse, Division of Psychiatry, data on file
   Google Scholar
• Matteo , P and Maremanni , I . 2005 . Methadone reduces need for psychiatric agents in heroin addicts hospitalized for panic and/or acute psychotic episodes . Heroin Add & Rel Clin Probl , 7 ( 4 ) : 43 – 8 .
   Google Scholar
• Cacciola , J , Alterman , A , Rutherford , M , McKay , J and Mulvaney , F . 2001 . The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients . Drug Alcohol Depend , 61 ( 3 ) : 271 – 80 .
   PubMed Web of Science ®Google Scholar
• Treece , C and Nicholson , B . 1980 . Personalilty type and dose levels in methadone maintenance . J Nerv Ment Dis , 168 ( 10 ) : 621 – 8 .
   PubMed Web of Science ®Google Scholar
• Bleich , A , Gelkopf , M , Weizman , T and Adelson , M . 2002 . Benzodiazepine abuse in a methadone maintenance treatment clinic in Israel: characteristics and a pharmacotherapeutic approach . Isr J Psychiatry Relat Sci , 39 ( 2 ) : 104 – 12 .
   PubMed Web of Science ®Google Scholar
• Tenore , P . Oct 2006 . Oct , CARF Review Data File, Albert Einstein College of Medicine Division of Substance Abuse, Division of Psychiatry, data on file
   Google Scholar
• McLellan , A T , Kushner , H , Metzger , D , Peters , R , Smith , I , Grissom , G , Pettinati , H and Argeriou , M . 1992 . The Fifth Edition of the Addiction Severity Index . J Subst Abuse Treat , 9 ( 3 ) : 199 – 213 .
   PubMed Web of Science ®Google Scholar
• Nunes , E , Quitkin , F , Brady , R and Post-Koenig , T . 1994 . Antidepressant treatment in methadone maintenance patients . J Addict Dis , 13 ( 3 ) : 13 – 24 .
   PubMed Web of Science ®Google Scholar
• O'Connor , P , Selwyn , P and Schottenfeld , R . 1994 . Medical care for injection-drug users . N Engl J Med , 331 ( 7 ) : 450 – 9 .
   PubMed Web of Science ®Google Scholar
• 1998 . National Consensus Development Panel on Effective Treatment of Opiate Addiction . JAMA , 280 : 1936 – 43 .
   PubMed Web of Science ®Google Scholar